| | | |
 
 
Collaborative Area of Innovation
 Quick Links
 
     
 

Frequently Asked Questions

Last updated: April 8, 2010, 12:20 p.m.
 
An information session was held on September 29th, 2010.
To download the PowerPoint presentation from the information session, click here.
To download a PDF of FAQs from the information session on September 29th, click here.

New: To download the FAQs for Registered Applicants from October 26, 2010, click here.
To download a PDF of general FAQs, click here.

FAQs for Registered Applicants:

Q: Are letters of support needed for the Letter of Intent?

A: No. Letters of support are not required for the Letter of Intent (LOI). However, letters of support will be required for the full proposal.


Q: Are the registration documents supposed to be submitted online or in hardcopy?

A: Online – please submit the documents via email as indicated in the RFP.


Q: If it is supposed to be submitted online, should all the documents (including the appendices and CV's) be submitted in PDF or as Word documents, etc.?

A: Either… a PDF would preserve your formatting.


Q: Is there a specific format for the CVs?

A: For the LOI, any format of CV is acceptable. For the full proposal, please submit the Canadian Common CV CIHR Registration CV.


Q: Can it be handed in using the UBC format?

A: For the LOI: Yes. For the full proposal, please submit the Canadian Common CV CIHR Registration CV.


Q: is there a length limit on the CV's? Should it be the full version or the condensed version?

A: For the LOI, no specific limit has been indicated. For the full proposal, please submit the Canadian Common CV CIHR Registration CV.


Q: Are there any other formatting guidelines that we should be aware of?

A: Only the formatting requirements that are specified in the RFP.



General FAQs:

Q: Approximately how many awards will be made; i.e. how much is the budget per team proposal?

A: One (1) team will be awarded this first Collaborative Area of Innovation with a budget of up to $2.25 million that must be spent within five years. If the external review that occurs 18-24 months after the initial award is successful, further funding may become available through the Foundation to continue to support the Collaborative Area of Innovation. This is the first call for proposals, and additional calls are planned in future years.

Q: Can I be on more than one application?
A: Yes. There is no limit on the number of proposals you can participate in, but only one will be funded at this time.

Q: Is the funding over two, three or five years?
A: The funding will be provided over 2-3 years and must be spent within five years of the initial award. There will be an external review in 2013, which will be 18-24 months after the initial award.

Q: Are co-PIs or co-leaders okay?
A: Yes; co-PIs or co-leaders can be named, but the proposal will need to demonstrate its ability to manage a budget of this size effectively. This is likely to be difficult if more than one person, or at most two people, is ultimately responsible for administration of the Collaborative Area of Innovation. In any case, there must be single nominated PI who is the contact for the proposal.

Q: Where are the guidelines for the letter of intent?
A: Visit the collaboration page. Click on “Request for proposals”. The PDF document includes the guidelines for the letter of intent on pages four and five.

Q: I'm wondering about the requirements for the team leader to have an affiliation with BC Children’s and/or BC Women’s and/or BC Mental Health. I am appointed at Simon Fraser University and I have a research membership with the Women's Health Research Institute at BC Women's. Do I meet the eligibility requirements for this opportunity?
A:
If you have a formal affiliation with one of the C&W hospitals, then you are eligible to apply. However, the Collaborative Area of Innovation must promote children’s health care and research.

Q: How important is the budget reduction going to factor into this? Is there a preference for cost-reducing Collaborative Area of Innovation proposals versus costexpanding Collaborative Area of Innovation proposals?
A:
The Collaborative Area of Innovation is supported by the BC Children’s Hospital Foundation and is intended to promote research and clinical innovations that are beyond the standard health care funded through PHSA. The proposal must have the ability to make a measurable improvement in children’s health, and one way this could be demonstrated is by improved cost effectiveness. However, other metrics of improvement in children’s health that do not involve cost savings could also be used. These might include, for example, reductions in morbidity, improved access, or better quality of life.

Q: Is it truly interdisciplinary, in terms of health professionals?
A:
The Collaborative Area of Innovation must involve collaboration across professional disciplines and medical specialties.

Q: What kind of health outputs are you looking for?
A:
We are looking for anything that improves child health. It has to be measurable and demonstrably a result of the activities of the Collaborative Area of Innovation, but beyond that it is up to you to define.

Q: How broad versus how focused should the proposal be?
A:
This is also up to you. It has to be focused enough to produce a demonstrable improvement in child health within 18-24 months. It has to be broad enough to be multidisciplinary, effectively collaborative, and so innovative and important that it knocks the socks off the reviewers.

Q: What is the successful team allowed to spend the money on?
A:
The money can be spent on whatever is necessary for your proposal to succeed – research or clinical personnel, equipment, operating expenses, or trainees. The money cannot be spent on routine patient care, but it can be spent in creative ways if you can justify the expense as essential for the success of your Collaborative Area of Innovation.

Q: Do you know of people who could help us put together the proposal?
A:
CFRI’s Research & Technology Development Office is not available to help with these proposals. The expertise of experienced clinician scientists, translational researchers, clinical coordinators, and research administrators throughout CFRI and its clusters can certainly be used.

Q: How will the unions be involved? (You can’t change health services and the roles of health professionals without involving the unions.)
A:
This depends entirely on the innovations that are proposed and what clinical and research activities are involved. Each proposal will have to describe how it would implement its Collaborative Area of Innovation if it is funded.

Q: Does the team have to be led by an MD?
A:
No. The team’s leader has to have a demonstrable capacity to lead and manage a Collaborative Area of Innovation that will be able to produce a measurable improvement in children’s health.

Q: Will the successful team’s activities have to go through ethics?
A:
It is very likely that the successful Collaborative Area of Innovation will involve human research that requires approval by the Research Ethics Board.

Q: For the successful proposal, who will sign off on the funding for ethics?
A:
The designated leader of the successful Collaborative Area of Innovation will be responsible for managing the budget and authorizing all expenditures.

Q: For the successful proposal, who will have signing authority for the money? Who will obtain the ethics approval?
A:
The designated leader of the successful Collaborative Area of Innovation will be responsible for managing the budget, authorizing all expenditures, and obtaining all Research Ethics Board and other administrative approvals required.

Q: Will the successful project get space?
A:
The successful Collaborative Area of Innovation will become a priority of the hospital, and as such will be in a favourable position to obtain clinical or research space, but it is impossible to provide a guarantee without knowing what is required. Some proposals may include a provision for renovation or other space accommodations within their budgets.

Additional FAQs from the information session on September 29th, 2010:


Q: Are there any historical models to inform our thinking?

A: No. This is a “made-in-B.C.” model that was created for this competition.


Q: Trying to provide demonstrable benefits within 18-24 months precludes most clinical trials. What type of evaluation and methodology can we use to demonstrate clinical benefits so quickly?

A: The structure you set up might include clinical trials to demonstrate benefits further into the future, but immediate benefits might be shown by translating advances from previous clinical trials into routine patient care and demonstrating your success at changing care in this way. Another possibility is implementing a new technology that has been shown to be effective elsewhere but is not currently available in B.C. You could also improve access to a therapeutic or diagnostic advance that is currently only available to a few of the children in B.C. who need it. There are many other possibilities as well, and we encourage you to think beyond the standard paradigm.


Q: What criteria will you give the review panel?

A: The same guidelines that you received for the letter of intent will be given to the review panel.


Q: You mentioned aspirations to overcome the “Ring Road” and to further the partnerships with UBC, the community, and other partners. How are the reviewers going to understand these needs? How will the external reviewers see the B.C. context?

A: Our external review panel is composed of individuals with a broad sense of child health research. They have a wide range of expertise that includes leadership of pediatric hospitals, pediatric research institutes, university pediatric departments, public health, public policy, and community pediatrics. In addition, the Executive Director of CFRI, who will provide staff support to the review panel, will be present for all of their deliberations and can assure that the panel is aware of the context in which child health research and care take place in B.C.


Note:
The Executive Director will not participate in any of the teams competing for a Collaborative Area of Innovation award, to avoid a conflict of interest.


Q: Doesn’t the review panel need some context for Canada and the way that things operate here?

A: Yes, of course. Three of the four members of the panel are familiar with the Canadian context, and the Executive Director of CFRI will be present for all panel deliberations and can also provide this context, if necessary.


Note:
The Executive Director will not participate in any of the teams competing for a Collaborative Area of Innovation award, to avoid a conflict of interest.


Q: Do you have any examples of interdisciplinary collaborations?

A:

CIHR Emerging Team Grant: Maternal Health - From Pre-conception to the Empty Nest
http://www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?prog=1012&view=seedlist&org=CIHR&type=AND&resultCount=25&sort=program&all=1&masterList=true&language=E


CIHR Terry Fox New Frontiers Program in Cancer
http://www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?prog=971&view=seedlist&org=CIHR&type=AND&resultCount=25&sort=program&all=1&masterList=true&language=E


Social Sciences and Humanities Research Council: Major Collaborative Research Initiatives (MCRI)
http://www.sshrc-crsh.gc.ca/funding-financement/programs-programmes/mcri-gtrc-eng.aspx#a1


International Polar Year science and research projects in Canada supported through funding from the Government of Canada

http://www.ipy-api.gc.ca/pg_IPYAPI_050-eng.html


Q: With the short timeline in which to achieve results, is it better to focus on one disease?

A: If it’s too broad, then it will be difficult to show anything concretely. If it’s too narrow, it is unlikely to be of sufficient scope or to have sufficient impact – so the application will need to strike a balance. It is up to you to convince the reviewers that you have found the right balance.


Q: I’d like to follow up on your comment about the registrations vs. the LOI – that following the registrations, you might encourage people to work together, yet there are only three days between the close of online registration and the deadline for submitting the letter of intent.

A: The registrations won’t be peer reviewed, and we encourage you to register immediately. If two letters of intent are submitted in the same area, then it is likely that both would suffer during the peer review process.


Q: Who is the leader for these applications – does it have to be an MD?

A: The leader does not have to be an MD but the leader does have to be associated with BC Children’s, BC Women’s and/or BC Mental Health. The leader must be someone who can convince the reviewers that she or he can develop, conduct and manage a research project of this size and scope.


Q: Can we involve investigators who are off-site?

A: Off-site investigators may be involved in the team, but the leader(s) of the project must be on the campus of BC Children’s, Sunny Hill, BC Women’s, and/or BC Mental Health.


Q: Do the projects need to improve child health specifically on this hospital campus?

A: The project need to improve child health, and we would expect this improvement to be seen on the BC Children’s Hospital or Sunny Hill campus at some point, but the initial effect could be demonstrated in the community or elsewhere in B.C.


Q: Can you clarify the timeline of money allocation vs. spending?

A: The funding will be given over three years and must be spent within five years.


Q: Is there any limitation on the number of LOIs (Letters of Intent) that an individual can participate in?

A: No, only one Collaborative Area of Innovation will be funded at this time. There is no reason why you can’t be involved in more than one letter of intent.

Q: Do you foresee any restrictions on the budget?

A: If it’s legal, spent in accordance with standard PHSA policy, and demonstrably required to achieve the goals of the project, then there are no further restrictions. We want to encourage innovation.


Q: One of my colleagues was at the meeting yesterday and heard that “we do not want single disease proposals”. Is that correct?

A: No. As long as the proposal will result in improved child health, is innovative and is collaborative, it is eligible for funding. However, it may be more difficult to demonstrate as great an impact with a single disease than it would be with a broader category of child health conditions.